Search filters

List of works by Naseema Gangat

20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients

scientific article published on 05 December 2018

A Population-based Study of Chronic Eosinophilic Leukemia-Not Otherwise Specified in the United States

scientific article published on 13 June 2020

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

scientific article published on 17 October 2018

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

scientific article published on 12 January 2018

Calculator-free point-of-care prognostication in myelodysplastic syndromes

scientific article published on 24 January 2019

Characteristics of patients with myelodysplastic syndrome with balanced translocations

scientific article published on 17 March 2020

Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

scientific article published on 26 January 2020

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

scientific article published on 17 October 2018

Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.

scientific article published on 22 November 2017

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis

scientific article published on 31 August 2018

Erythrocytosis associated with cerebral hemangiomas and multiple venous anomalies

scientific article published on 29 June 2020

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

scientific article published on 14 June 2019

Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes

scientific article published on 09 October 2018

JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease

scientific article published on 23 December 2017

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

scientific article published on 19 December 2017

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

scientific article published on 16 January 2020

Mutations and karyotype predict treatment response in myelodysplastic syndromes

scientific article published on 30 September 2018

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

scientific article published on 8 February 2018

Myelofibrosis biology and contemporary management

scientific article published on 20 March 2020

Myeloproliferative neoplasms and pregnancy: overview and practice recommendations

scientific article published on 09 December 2020

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

scientific article published on 27 September 2018

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

scientific article published on 11 April 2018

Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic

scientific article published on 30 April 2020

Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases

scientific article

Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients

scientific article published on 05 October 2018

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

scientific article published on 03 May 2019

The Differential Diagnosis of Basophilia in Patients Undergoing BCR-ABL Testing

scientific article published on 20 April 2020

The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

scientific article published on 02 October 2018

The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis

scientific article published on 05 December 2018

The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes

scientific article published on 06 May 2018

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.

scientific article published on 11 October 2017

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates

scientific article published on 06 April 2018

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients

scientific article published on 24 August 2020

Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points

scientific article published on 23 November 2020

WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic

scientific article published on 03 April 2020